<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu K</submitter><funding>College Students' Innovative Entrepreneurial Training Plan Program</funding><funding>College Students’ Innovative Entrepreneurial Training Plan Program</funding><funding>the National Natural Science Foundation of China</funding><pagination>50</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12876095</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>49(1)</volume><pubmed_abstract>Ferroptosis, an iron-dependent form of cell death driven by lipid peroxidation, plays a critical role in the progression of asthma, yet its therapeutic modulation remains underexplored. Luteolin (Lut), a natural flavonoid known for its anti-inflammatory properties, presents a potential candidate for targeting ferroptosis in asthma. However, the precise mechanisms underlying its therapeutic effects are unclear. This study used a combination of bioinformatics, network pharmacology, molecular docking, and in vitro and in vivo experiments to investigate the role of luteolin in the treatment of ferroptosis in asthma. A collection of natural flavonoid compounds with high oral bioavailability and drug-like properties was assembled from the Chinese herbal medicine database. Through network pharmac</pubmed_abstract><journal>Inflammation</journal><pubmed_title>Luteolin Attenuates Asthma Via Inhibiting ALOX15 Mediated Bronchial Epithelial Cell Ferroptosis.</pubmed_title><pmcid>PMC12876095</pmcid><funding_grant_id>(202410571002, S202510571072, S202510571064)</funding_grant_id><funding_grant_id>(82370564)</funding_grant_id><pubmed_authors>Liu K</pubmed_authors><pubmed_authors>Huang T</pubmed_authors><pubmed_authors>Lai T</pubmed_authors><pubmed_authors>Qiu S</pubmed_authors><pubmed_authors>Luo L</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Deng M</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Luteolin Attenuates Asthma Via Inhibiting ALOX15 Mediated Bronchial Epithelial Cell Ferroptosis.</name><description>Ferroptosis, an iron-dependent form of cell death driven by lipid peroxidation, plays a critical role in the progression of asthma, yet its therapeutic modulation remains underexplored. Luteolin (Lut), a natural flavonoid known for its anti-inflammatory properties, presents a potential candidate for targeting ferroptosis in asthma. However, the precise mechanisms underlying its therapeutic effects are unclear. This study used a combination of bioinformatics, network pharmacology, molecular docking, and in vitro and in vivo experiments to investigate the role of luteolin in the treatment of ferroptosis in asthma. A collection of natural flavonoid compounds with high oral bioavailability and drug-like properties was assembled from the Chinese herbal medicine database. Through network pharmac</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-15T09:16:05.892Z</modification><creation>2026-07-02T03:08:59.864Z</creation></dates><accession>S-EPMC12876095</accession><cross_references><pubmed>41547709</pubmed><doi>10.1007/s10753-025-02421-2</doi></cross_references></HashMap>